Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EFTR
DateTimeSourceHeadlineSymbolCompany
21/02/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
21/02/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
10/02/202401:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EFTReFFECTOR Therapeutics Inc
30/01/202413:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
26/01/202421:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
26/01/202421:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
10/01/202413:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
10/01/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
08/01/202413:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/01/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
08/12/202313:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/12/202313:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
28/11/202313:18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
28/11/202313:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
13/11/202321:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
13/11/202321:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
11/09/202321:58Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
11/09/202321:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202321:36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202321:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202321:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202321:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
04/08/202321:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
04/08/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
04/08/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
27/06/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EFTReFFECTOR Therapeutics Inc
23/06/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202311:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202311:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202311:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EFTReFFECTOR Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:EFTR

Your Recent History

Delayed Upgrade Clock